CN Stock MarketDetailed Quotes

688443 Chongqing Genrix Biopharmaceutical

Watchlist
  • 25.29
  • -0.49-1.90%
Post Market Oct 16 15:00 CST
9.27BMarket Cap-11963P/E (TTM)

Chongqing Genrix Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-90.47%12.66K
-93.67%6.33K
154.92%1.21M
-69.59%139.13K
-70.57%132.8K
1,479.93%100.01K
-98.79%475.24K
148.83%457.59K
451.26K
6.33K
Operating revenue
-90.47%12.66K
-93.67%6.33K
154.92%1.21M
-69.59%139.13K
-70.57%132.8K
1,479.93%100.01K
-98.79%475.24K
148.83%457.59K
--451.26K
--6.33K
Total operating cost
-7.28%363.52M
-18.53%164.59M
26.40%815.12M
25.71%576M
48.51%392.06M
143.25%202.04M
72.72%644.89M
458.21M
264M
83.06M
Operating cost
-95.59%4.36K
-97.73%2.18K
39.78%739.8K
-80.66%101.06K
-80.42%98.88K
4,298.32%95.92K
-97.27%529.27K
--522.43K
--505.01K
--2.18K
Operating tax surcharges
20.32%1.35M
21.76%675.29K
-10.17%2.56M
-9.62%1.68M
-13.53%1.12M
-23.73%554.6K
7.31%2.85M
--1.86M
--1.3M
--727.13K
Operating expense
12,257.38%36.97M
--12.4M
--10.43M
--1.74M
--299.17K
----
----
----
----
----
Administration expense
-26.45%61.88M
-39.59%27.9M
6.34%163.36M
13.51%120.97M
37.88%84.14M
267.84%46.18M
534.37%153.62M
--106.57M
--61.02M
--12.56M
Financial expense
-213.99%-20.24M
-172.30%-6.31M
-47.18%17.64M
-33.92%16.31M
13.77%17.76M
21.39%8.73M
5.06%33.4M
--24.69M
--15.61M
--7.19M
-Interest expense (Financial expense)
-28.23%13.12M
-20.60%7.03M
6.84%34.99M
16.86%27.73M
20.39%18.28M
21.93%8.86M
1.01%32.75M
--23.73M
--15.19M
--7.26M
-Interest Income (Financial expense)
-5,182.42%-33.37M
-22,497.04%-13.35M
-10,742.26%-17.46M
-10,853.62%-11.53M
-824.11%-631.72K
-58.13%-59.06K
60.41%-161.07K
---105.25K
---68.36K
---37.35K
Research and development
-1.76%283.55M
-11.29%129.93M
36.50%620.4M
34.08%435.19M
55.55%288.65M
134.05%146.47M
53.90%454.49M
--324.57M
--185.56M
--62.58M
Credit Impairment Loss
57.66%-633.03
94.39%-316.51
----
----
94.13%-1.5K
-1,534.23%-5.64K
----
---1.04K
---25.47K
---345
Asset Impairment Loss
-110.46%-86.47K
90.16%-60.6K
178.40%975.29K
201.31%1.01M
1,093.27%826.31K
-1,034.18%-615.67K
-364.69%-1.24M
---1M
---83.19K
---54.28K
Other net revenue
Fair value change income
----
----
-72.80%1.94M
-70.75%1.78M
-60.91%1.56M
-53.52%898.02K
73.68%7.14M
--6.07M
--3.98M
--1.93M
Invest income
--11.12K
--11.12K
----
----
----
----
3,324.24%719.73K
--719.73K
--719.73K
----
Asset deal income
---1.75K
----
----
----
----
----
--475.24
--475.24
----
----
Other revenue
18.03%1.65M
25.65%874.47K
-84.25%9.68M
120.18%4.84M
3.51%1.4M
0.16%695.96K
614.97%61.44M
--2.2M
--1.35M
--694.88K
Operating profit
6.76%-361.93M
18.51%-163.76M
-39.03%-801.32M
-26.34%-568.23M
-50.68%-388.15M
-149.71%-200.96M
-79.16%-576.36M
-93.08%-449.77M
-257.6M
-80.48M
Add:Non operating Income
----
----
3,058,314.12%26K
----
----
----
-99.85%0.85
--0.85
--0.85
----
Less:Non operating expense
-11.79%4.62K
44.73%6.16K
1,517.98%29.41K
438.16%9.33K
212.49%5.24K
--4.26K
-99.58%1.82K
--1.73K
--1.68K
----
Total profit
6.76%-361.93M
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
-92.73%-449.77M
-257.61M
-80.48M
Net profit
FPtoL-361.93M
FPtoL-163.77M
FPtoL-801.32M
FPtoL-568.24M
FPtoL-388.15M
FPtoL-200.97M
FPtoL-576.37M
FPtoL-449.77M
-257.61M
-80.48M
Net profit from continuing operation
6.76%-361.93M
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
---449.77M
---257.61M
---80.48M
Net profit of parent company owners
6.76%-361.93M
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
-92.73%-449.77M
---257.61M
---80.48M
Earning per share
Basic earning per share
29.79%-0.99
38.36%-0.45
-19.05%-2.5
-13.41%-1.86
-50.00%-1.41
-151.72%-0.73
-79.49%-2.1
---1.64
---0.94
---0.29
Diluted earning per share
29.79%-0.99
38.36%-0.45
-19.05%-2.5
-13.41%-1.86
-50.00%-1.41
-151.72%-0.73
-79.49%-2.1
---1.64
---0.94
---0.29
Other composite income
Total composite income
6.76%-361.93M
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
-449.77M
-257.61M
-80.48M
Total composite income of parent company owners
6.76%-361.93M
----
----
-26.34%-568.24M
-50.68%-388.15M
----
----
---449.77M
---257.61M
---80.48M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
--
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -90.47%12.66K-93.67%6.33K154.92%1.21M-69.59%139.13K-70.57%132.8K1,479.93%100.01K-98.79%475.24K148.83%457.59K451.26K6.33K
Operating revenue -90.47%12.66K-93.67%6.33K154.92%1.21M-69.59%139.13K-70.57%132.8K1,479.93%100.01K-98.79%475.24K148.83%457.59K--451.26K--6.33K
Total operating cost -7.28%363.52M-18.53%164.59M26.40%815.12M25.71%576M48.51%392.06M143.25%202.04M72.72%644.89M458.21M264M83.06M
Operating cost -95.59%4.36K-97.73%2.18K39.78%739.8K-80.66%101.06K-80.42%98.88K4,298.32%95.92K-97.27%529.27K--522.43K--505.01K--2.18K
Operating tax surcharges 20.32%1.35M21.76%675.29K-10.17%2.56M-9.62%1.68M-13.53%1.12M-23.73%554.6K7.31%2.85M--1.86M--1.3M--727.13K
Operating expense 12,257.38%36.97M--12.4M--10.43M--1.74M--299.17K--------------------
Administration expense -26.45%61.88M-39.59%27.9M6.34%163.36M13.51%120.97M37.88%84.14M267.84%46.18M534.37%153.62M--106.57M--61.02M--12.56M
Financial expense -213.99%-20.24M-172.30%-6.31M-47.18%17.64M-33.92%16.31M13.77%17.76M21.39%8.73M5.06%33.4M--24.69M--15.61M--7.19M
-Interest expense (Financial expense) -28.23%13.12M-20.60%7.03M6.84%34.99M16.86%27.73M20.39%18.28M21.93%8.86M1.01%32.75M--23.73M--15.19M--7.26M
-Interest Income (Financial expense) -5,182.42%-33.37M-22,497.04%-13.35M-10,742.26%-17.46M-10,853.62%-11.53M-824.11%-631.72K-58.13%-59.06K60.41%-161.07K---105.25K---68.36K---37.35K
Research and development -1.76%283.55M-11.29%129.93M36.50%620.4M34.08%435.19M55.55%288.65M134.05%146.47M53.90%454.49M--324.57M--185.56M--62.58M
Credit Impairment Loss 57.66%-633.0394.39%-316.51--------94.13%-1.5K-1,534.23%-5.64K-------1.04K---25.47K---345
Asset Impairment Loss -110.46%-86.47K90.16%-60.6K178.40%975.29K201.31%1.01M1,093.27%826.31K-1,034.18%-615.67K-364.69%-1.24M---1M---83.19K---54.28K
Other net revenue
Fair value change income ---------72.80%1.94M-70.75%1.78M-60.91%1.56M-53.52%898.02K73.68%7.14M--6.07M--3.98M--1.93M
Invest income --11.12K--11.12K----------------3,324.24%719.73K--719.73K--719.73K----
Asset deal income ---1.75K----------------------475.24--475.24--------
Other revenue 18.03%1.65M25.65%874.47K-84.25%9.68M120.18%4.84M3.51%1.4M0.16%695.96K614.97%61.44M--2.2M--1.35M--694.88K
Operating profit 6.76%-361.93M18.51%-163.76M-39.03%-801.32M-26.34%-568.23M-50.68%-388.15M-149.71%-200.96M-79.16%-576.36M-93.08%-449.77M-257.6M-80.48M
Add:Non operating Income --------3,058,314.12%26K-------------99.85%0.85--0.85--0.85----
Less:Non operating expense -11.79%4.62K44.73%6.16K1,517.98%29.41K438.16%9.33K212.49%5.24K--4.26K-99.58%1.82K--1.73K--1.68K----
Total profit 6.76%-361.93M18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M-92.73%-449.77M-257.61M-80.48M
Net profit FPtoL-361.93MFPtoL-163.77MFPtoL-801.32MFPtoL-568.24MFPtoL-388.15MFPtoL-200.97MFPtoL-576.37MFPtoL-449.77M-257.61M-80.48M
Net profit from continuing operation 6.76%-361.93M18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M---449.77M---257.61M---80.48M
Net profit of parent company owners 6.76%-361.93M18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M-92.73%-449.77M---257.61M---80.48M
Earning per share
Basic earning per share 29.79%-0.9938.36%-0.45-19.05%-2.5-13.41%-1.86-50.00%-1.41-151.72%-0.73-79.49%-2.1---1.64---0.94---0.29
Diluted earning per share 29.79%-0.9938.36%-0.45-19.05%-2.5-13.41%-1.86-50.00%-1.41-151.72%-0.73-79.49%-2.1---1.64---0.94---0.29
Other composite income
Total composite income 6.76%-361.93M18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M-449.77M-257.61M-80.48M
Total composite income of parent company owners 6.76%-361.93M---------26.34%-568.24M-50.68%-388.15M-----------449.77M---257.61M---80.48M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion--------------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data